Sofinnova Investments’s MediciNova MNOV Stock Holding History

Sofinnova Investments’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-32,875	Closed	-$336K	–	65
2018 Q1	$336K	Buy	+32,875	New	+$328K	0.06%	40

Other funds holding MNOV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Sofinnova Investments's MNOV Position: Q2 2018 in Review

Sofinnova Investments sold out of MediciNova (MNOV) in Q2 2018, closing a stake of 32,875 shares — an estimated $336K sold.

Sofinnova Investments first reported a position in MNOV in Q1 2018 and held it in 1 quarter. The position peaked at $336K in Q1 2018. 55 funds tracked by Wall St. Rank hold MNOV as of Q2 2018.

Sofinnova Investments reported no remaining MediciNova position as of Q2 2018 after selling out during the quarter.
Sofinnova Investments sold 32,875 MediciNova shares in Q2 2018, an estimated $336K.
Sofinnova Investments first reported a position in MediciNova in Q1 2018 and held it in 1 quarter.
Sofinnova Investments's MediciNova position peaked at $336K in Q1 2018.
55 funds tracked by Wall St. Rank held MediciNova as of Q2 2018.

Based on Sofinnova Investments's 13F filing for Q2 2018, filed 14 Aug 2018.